Strategies to Help Improve Clinical Trial Diversity and Inclusion
From Engaging Locally to Removing Financial Obstacles
With health equity at the forefront of many conversations today, study sponsors are seeking ways to make clinical trial participation more inclusive.
At BBK Worldwide, we believe that clinical trials for investigational treatments should reflect the populations that could benefit from them, with the long-term goal of achieving better health interventions for those in greatest need. To help facilitate participation of underserved populations, we have outlined strategic guidance that study sponsors can leverage in their efforts.